{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:19:06Z","timestamp":1792509546693,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.gim.2022.03.021","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T08:27:09Z","timestamp":1650961629000},"page":"1425-1436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2031-7817","authenticated-orcid":false,"given":"Melissa","family":"Wasserstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Arash-Kaps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata C.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto Bernardo","family":"Guelbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lidove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Mabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eubekir","family":"Senates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Tchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Villarrubia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Furey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atef","family":"Zaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.gim.2022.03.021_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B Niemann-Pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.gim.2022.03.021_bib2","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1542\/peds.2004-0887","article-title":"The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study","volume":"114","author":"Wasserstein","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.gim.2022.03.021_bib3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jpeds.2006.06.034","article-title":"Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease","volume":"149","author":"Wasserstein","year":"2006","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gim.2022.03.021_bib4","first-page":"100626","article-title":"Autopsy pathology of infantile neurovisceral ASMD (Niemann-Pick disease type A): clinicopathologic correlations of a case report","volume":"24","author":"Thurberg","year":"2020","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"10.1016\/j.gim.2022.03.021_bib5","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1542\/peds.2007-3016","article-title":"A\u00a0prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B","volume":"122","author":"McGovern","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.gim.2022.03.021_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","article-title":"Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)","volume":"12","author":"McGovern","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.gim.2022.03.021_bib7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann-Pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.gim.2022.03.021_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13023-021-01842-0","article-title":"Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation","volume":"16","author":"McGovern","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gim.2022.03.021_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2020.02.002","article-title":"Biochemical and imaging parameters in acid sphingomyelinase deficiency: potential utility as biomarkers","volume":"130","author":"Eskes","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"1-2","key":"10.1016\/j.gim.2022.03.021_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2020.06.008","article-title":"Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy","volume":"131","author":"Jones","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1016\/j.gim.2022.03.021_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/PAS.0b013e31825793ff","article-title":"Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B)","volume":"36","author":"Thurberg","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.gim.2022.03.021_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13023-021-01739-y","article-title":"Changes in PCSK 9 and apolipoprotein B100 in Niemann-Pick disease after enzyme replacement therapy with olipudase alfa","volume":"16","author":"Garside","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.gim.2022.03.021_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2016.05.001","article-title":"Cause of death in patients with\u00a0chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): literature review and report of new cases","volume":"118","author":"Cassiman","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"1-2","key":"10.1016\/j.gim.2022.03.021_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2015.05.013","article-title":"Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency","volume":"116","author":"Wasserstein","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.gim.2022.03.021_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10545-017-0123-6","article-title":"Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months","volume":"41","author":"Wasserstein","year":"2018","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"8","key":"10.1016\/j.gim.2022.03.021_bib16","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41436-021-01156-3","article-title":"One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency","volume":"23","author":"Diaz","year":"2021","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.gim.2022.03.021_bib17","first-page":"185","article-title":"Standardized single breath normal values for carbon monoxide diffusing capacity","volume":"123","author":"Crapo","year":"1981","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.gim.2022.03.021_bib18","first-page":"440","article-title":"Using and interpreting carbon monoxide diffusing capacity (DLco) correctly","volume":"56","author":"Nguyen","year":"2016","journal-title":"Consultant"},{"issue":"4)(suppl 5","key":"10.1016\/j.gim.2022.03.021_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.gim.2022.03.021_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.gim.2022.03.021_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2011-01-328955","article-title":"The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients","volume":"118","author":"Scherber","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gim.2022.03.021_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1148\/radiol.2381041696","article-title":"Type B Niemann-Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing","volume":"238","author":"Mendelson","year":"2006","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.gim.2022.03.021_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2004.02.048","article-title":"Lipid abnormalities in children with types A and B Niemann Pick disease","volume":"145","author":"McGovern","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"1-2","key":"10.1016\/j.gim.2022.03.021_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ymgme.2020.06.010","article-title":"Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42 months of treatment","volume":"131","author":"Thurberg","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"9","key":"10.1016\/j.gim.2022.03.021_bib25","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/PAS.0000000000000659","article-title":"Clearance of hepatic sphingomyelin by olipudase alfa is associated with improvement in lipid profiles in acid sphingomyelinase deficiency","volume":"40","author":"Thurberg","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gim.2022.03.021_bib26","series-title":"Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual","first-page":"587","article-title":"Screening for lysosomal disorders","author":"Wenger","year":"1991"},{"issue":"5","key":"10.1016\/j.gim.2022.03.021_bib28","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.gim.2022.03.021_bib29","series-title":"StatPearls","article-title":"Diffusing capacity of the lungs for carbon monoxide","author":"Modi","year":"2021"},{"issue":"2","key":"10.1016\/j.gim.2022.03.021_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymgme.2018.11.014","article-title":"Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)","volume":"126","author":"Wasserstein","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.gim.2022.03.021_bib31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00408-016-9893-0","article-title":"Pulmonary involvement in Niemann-Pick disease: a state-of-the-art review","volume":"194","author":"von Ranke","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.gim.2022.03.021_bib32","first-page":"217","article-title":"Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: The utility of animal models of disease in the toxicological evaluation of potential therapeutics","volume":"2","author":"Murray","year":"2014","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.gim.2022.03.021_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/gim.2015.24","article-title":"Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant\u00a0human acid sphingomyelinase) in adults with Niemann\u2013Pick\u00a0disease type B (acid sphingomyelinase deficiency)","volume":"18","author":"McGovern","year":"2016","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gim.2022.03.021_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00330-004-2554-3","article-title":"Imaging of macrophage-related lung diseases","volume":"15","author":"Marten","year":"2005","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.gim.2022.03.021_bib35","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3892\/etm.2016.3683","article-title":"Hypersplenism: history and current status","volume":"12","author":"Lv","year":"2016","journal-title":"Exp Ther Med"},{"issue":"9","key":"10.1016\/j.gim.2022.03.021_bib36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3324\/haematol.2014.119545","article-title":"A\u00a0pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis","volume":"100","author":"Vannucchi","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.gim.2022.03.021_bib37","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1208\/s12248-017-0153-x","article-title":"Recommendations for the assessment and management of pre-existing drug-reactive antibodies during biotherapeutic development","volume":"19","author":"Xue","year":"2017","journal-title":"AAPS J"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109836002200716X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109836002200716X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:51:42Z","timestamp":1761097902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109836002200716X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S109836002200716X"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2022.03.021","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2022.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}]}}